Three-Statement Breakdown
REVENUE UP
Revenue rose 2.4% year over year to $85.1B, and carried a 4.9% net margin.
REVENUE
+2.4%
85,138
GROSS PROFIT
—
—
NET INCOME
-45.8%
4,183
EPS (DILUTED)
-43.2%
$1.00
| Income statement | 24-06 | 24-09 | 24-12 | 25-03 | 25-06 | 25-09 | 25-12 | QoQ | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 93,060 | 90,016 | 83,426 | 83,130 | 81,506 | 85,294 | 82,308 | 85,138 | +3.4% | +2.4% | |
| SG&A | (2,568) | (2,296) | (2,617) | (2,540) | (2,528) | (3,032) | (3,028) | (2,684) | -11.4% | +5.7% | |
| Interest expense | (271) | (207) | (297) | (205) | (145) | (90) | (163) | (295) | +81.0% | +43.9% | |
| Income tax | (4,094) | (4,055) | (1,858) | (3,567) | (3,351) | (3,164) | (1,422) | (2,495) | +75.5% | -30.1% | |
| Net income | 9,240 | 8,610 | 7,610 | 7,713 | 7,082 | 7,548 | 6,501 | 4,183 | -35.7% | -45.8% | |
| EPS (diluted) |
NOT DISCLOSED
10-Q
|
$2.14 | $1.92 | — | $1.76 | $1.64 | $1.76 | — | $1.00 | — | -43.2% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-05-04 ↗